Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.

ABSTRACT:

SUBMITTER: Toback S 

PROVIDER: S-EPMC8598212 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature